ctDNA Archives - Geneseeq Technology Inc. | A Precision Oncology Company

August 26, 2026

Beyond Mutation-Only MRD: Making Better Use of ctDNA Data

May 25, 2023

GENESEEQ TO SHOWCASE NEW FINDINGS AT ASCO 2023

May 16, 2023

Geneseeq published new research on the clinical use of circulating-free DNA fragmentomic in monitoring minimal residual disease for patients with non-small-cell lung cancer

October 18, 2022

Geneseeq study highlights ctDNA monitoring clinical value in colorectal cancer patients resistant to BRAF/EGFR-targeted therapy

August 31, 2021

Geneseeq Study Evaluates ctDNA MRD to Predict Response to Therapy and Assess Prognosis in Locally Advanced Rectal Cancer

May 26, 2021

Geneseeq Presenting Data at the American Society of Clinical Oncology Annual Meeting 2021